| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Georgios D Panos | Q41621744 |
| P2093 | author name string | Horace Massa | |
| Athanasios Vergados | |||
| Sudeshna Patra | |||
| Spyros Y Pipis | |||
| Temilade Adewoyin | |||
| P2860 | cites work | USE OF A THRESHOLD OF INTERLEUKIN-10 AND IL-10/IL-6 RATIO IN OCULAR SAMPLES FOR THE SCREENING OF VITREORETINAL LYMPHOMA. | Q47600507 |
| The Impact and Implication of Peripheral Vascular Leakage on Ultra-Widefield Fluorescein Angiography in Uveitis. | Q47648347 | ||
| Uveitis in Patients with Retinitis Pigmentosa: 30 Years' Consecutive Data | Q47902334 | ||
| Pattern of uveitis in a referral uveitis clinic in India | Q48036559 | ||
| Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis | Q48527924 | ||
| Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients. | Q48637345 | ||
| Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis | Q48693121 | ||
| Adalimumab in Patients with Active Noninfectious Uveitis. | Q49025036 | ||
| Incidence of Cystoid Macular Edema After Descemet Membrane Endothelial Keratoplasty. | Q49342269 | ||
| Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review | Q49350278 | ||
| Macular Edema in Childhood Uveitis | Q49922196 | ||
| Irvine-Gass Macular Edema Responding to the Combination of Oral Mineralocorticoid-Receptor Antagonist With Dexamethasone Drops | Q50091765 | ||
| Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients. | Q50245165 | ||
| Incidence and prevalence of different uveitis entities in Finland. | Q50620750 | ||
| Uveitis in the southeastern United States. | Q50936319 | ||
| Aquaporin-1 channels in human retinal pigment epithelium: role in transepithelial water movement | Q24302545 | ||
| Intraocular and serum cytokine profiles in patients with intermediate uveitis | Q24619574 | ||
| Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop | Q24727581 | ||
| Ocular findings in systemic lupus erythematosus | Q26743822 | ||
| Pathophysiology and new treatment of uveitis | Q27014100 | ||
| The effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocol | Q28068067 | ||
| Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner | Q28267444 | ||
| Ocular inflammation alters swelling and membrane characteristics of rat Müller glial cells | Q28574115 | ||
| Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease | Q30054715 | ||
| Epidemiology of uveitis in the mid-Atlantic United States | Q30279210 | ||
| Fingolimod therapy for multiple sclerosis | Q30633055 | ||
| Grid laser photocoagulation for macular oedema in uveitis or the Irvine-Gass syndrome | Q31931806 | ||
| Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide | Q33193362 | ||
| Discrepancy between fluorescein angiography and optical coherence tomography in detection of macular disease | Q33327337 | ||
| The problem of uveitis in Bendel State of Nigeria: experience in Benin City | Q33650433 | ||
| Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients | Q33774951 | ||
| Choroidal white lesions as an early manifestation of sarcoidosis | Q33851477 | ||
| Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. | Q33920749 | ||
| Quality of life in non-infectious uveitis patients on immunosuppressive therapy | Q34008346 | ||
| Etiology and treatment of the inflammatory causes of cystoid macular edema | Q34077613 | ||
| Uveitis: a global perspective | Q34213270 | ||
| Fingolimod-associated macular edema: incidence, detection, and management | Q34257297 | ||
| Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study | Q34305621 | ||
| Wide-field retinal imaging in the management of noninfectious posterior uveitis | Q34398454 | ||
| Systemic disorders associated with episcleritis and scleritis | Q34457725 | ||
| Fundus autofluorescence imaging of the white dot syndromes. | Q34511339 | ||
| Prostaglandins and cystoid macular edema | Q34805143 | ||
| Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema | Q35065882 | ||
| Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCζ in the Goto Kakizaki rat model | Q35168171 | ||
| Population based assessment of uveitis in an urban population in southern India | Q35315057 | ||
| Sarcoidosis in the national veteran population: association of ocular inflammation and mortality | Q35554332 | ||
| Degree, duration, and causes of visual loss in uveitis. | Q35592376 | ||
| Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis | Q35669508 | ||
| HLA-B27-associated acute anterior uveitis in the University Referral Centre in North Thailand: clinical presentation and visual prognosis. | Q35762754 | ||
| Intermediate uveitis in a pediatric Italian population | Q85039809 | ||
| Birdshot chorioretinopathy | Q85292387 | ||
| [Anterior chamber migration of intravitreal dexamethasone implant (Ozurdex®) in pseudophakic eyes: report of three cases] | Q85895576 | ||
| Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study | Q86518739 | ||
| Anti-TNF-α agents for refractory cystoid macular edema associated with noninfectious uveitis | Q86998635 | ||
| Development of macular edema and impact on visual acuity in uveitis associated with juvenile idiopathic arthritis | Q87070301 | ||
| Intravitreal Ranibizumab for the Treatment of Irvine-Gass Syndrome | Q87547608 | ||
| Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome | Q87639115 | ||
| [Vogt-Koyanagi-Harada disease] | Q88231898 | ||
| Fluocinolone acetonide intravitreal implant (Retisert® ) in the treatment of sight threatening macular oedema of juvenile idiopathic arthritis-related uveitis | Q88359193 | ||
| Juvenile idiopathic arthritis-associated uveitis | Q88719901 | ||
| European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1 | Q88735767 | ||
| Uveitis and spondyloarthropathies | Q90222640 | ||
| Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED Study Report 2 | Q90588698 | ||
| The use of biologic agents in the management of uveitis | Q90734396 | ||
| Taxane Induced Cystoid Macular Edema: Case Report and Integrated Pathogenic Theory | Q91194930 | ||
| Drug-induced uveitis | Q91482397 | ||
| Visual and Clinical Outcome of Macular Edema Complicating Pediatric Noninfectious Uveitis | Q91648684 | ||
| Topical non-steroidal anti-inflammatory drugs for the treatment of cystoid macular edema post Descemet's stripping automated endothelial keratoplasty | Q91748112 | ||
| Real-world evidence of treatment for relapse of noninfectious uveitis in tertiary centers in Japan: A multicenter study | Q92006163 | ||
| Epidemiology of Macular Edema in Uveitis | Q92035582 | ||
| Dexamethasone intravitreal implant (OZURDEX®) for macular edema secondary to noninfectious uveitis: a review of the literature | Q92654587 | ||
| Sarcoidosis | Q93199886 | ||
| Modes of action of second-line agents | Q39600367 | ||
| Spectral-domain optical coherence tomography findings of the macula in 500 consecutive patients with uveitis. | Q40661330 | ||
| Characterization of phenotype and cytokine profiles of T cell lines derived from vitreous humour in ocular inflammation in man. | Q40949815 | ||
| Ocular Behçet's Disease: Changing Patterns Over Time, Complications and Long-Term Visual Prognosis. | Q41003032 | ||
| Visual Prognosis and Ocular Complications in Herpetic versus HLA-B27- or Ankylosing Spondylitis-associated Anterior Uveitis | Q41622085 | ||
| Interferon-α 2b Enhances Barrier Function of Bovine Retinal Microvascular Endothelium in Vitro | Q41680298 | ||
| Ocular Autoimmune Systemic Inflammatory Infectious Study - Report 3: Posterior and Panuveitis | Q41989664 | ||
| Differential expression of Kir4.1 and aquaporin 4 in the retina from endotoxin-induced uveitis rat | Q42171317 | ||
| NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema | Q43154284 | ||
| Fundus autofluorescence and spectral domain optical coherence tomography in uveitic macular edema | Q43294434 | ||
| Changing patterns of intraocular inflammatory disease in Japan | Q43876674 | ||
| Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use. | Q43934938 | ||
| Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab | Q44499631 | ||
| Pars planitis in the Mexican Mestizo population: ocular findings, treatment, and visual outcome | Q44508771 | ||
| Sirolimus-induced pneumonitis, sinusitis and macular oedema | Q45117082 | ||
| Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases | Q45241038 | ||
| Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. | Q45958318 | ||
| Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group | Q46047853 | ||
| Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema | Q46062208 | ||
| Prognostic factors in uveitis | Q46340309 | ||
| Optical coherence tomography assessment of the vitreoretinal relationship in diabetic macular edema | Q46462691 | ||
| Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography. | Q46520542 | ||
| Mycophenolate mofetil therapy for inflammatory eye disease | Q46629616 | ||
| Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil. | Q46735961 | ||
| COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis | Q47107888 | ||
| Uveitis–Glaucoma–Hyphaema Syndrome. General review | Q47111520 | ||
| Comprehensive analysis of vitreous specimens for uveitis classification: a prospective multicentre observational study. | Q47112562 | ||
| Patterns of uveitis in the middle East and europe | Q35835596 | ||
| Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. | Q35928698 | ||
| Epidemiology of uveitis | Q36080366 | ||
| Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Tr | Q36090279 | ||
| Pattern of uveitis in a referral centre in Tunisia, North Africa | Q36282084 | ||
| Müller cells in the healthy and diseased retina | Q36535340 | ||
| Primary intraocular lymphoma: A review | Q36567087 | ||
| Pars plasma vitrectomy in the management of the Irvine-Gass syndrome. | Q36653086 | ||
| Drug-induced uveitis | Q36797491 | ||
| The impact of macular edema on visual function in intermediate, posterior, and panuveitis. | Q36814725 | ||
| Association of Vogt Koyanagi Harada Syndrome and Seronegative Rheumatoid Arthritis. | Q36893486 | ||
| Biologics in the treatment of uveitis | Q37046546 | ||
| International Uveitis Study Group (IUSG): clinical classification of uveitis | Q37124620 | ||
| Diagnostic vitrectomy for the diagnosis and management of posterior uveitis of unknown etiology | Q37137449 | ||
| Causes and frequency of blindness in patients with intraocular inflammatory disease | Q37319691 | ||
| Birdshot uveitis: current and emerging treatment options | Q37412317 | ||
| Clinical review: Anti-TNFalpha therapies in uveitis: perspective on 5 years of clinical experience | Q37650221 | ||
| Postsurgical cystoid macular edema. | Q37779453 | ||
| Review on the worldwide epidemiology of uveitis | Q38105516 | ||
| Surgical treatment for macular edema | Q38177288 | ||
| Retinal imaging in uveitis | Q38213028 | ||
| Association of Disorganization of Retinal Inner Layers With Visual Acuity In Eyes With Uveitic Cystoid Macular Edema | Q38380311 | ||
| Filgotinib for the treatment of rheumatoid arthritis | Q38609755 | ||
| A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients | Q38655435 | ||
| TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA. | Q38777213 | ||
| The safety of ustekinumab for the treatment of psoriatic arthritis | Q38820480 | ||
| Uveitic macular edema. | Q38852119 | ||
| Sub-Tenon Injections of Triamcinolone Acetonide Had Limited Effect on Cystoid Macular Edema Secondary to Nanoparticle Albumin-Bound-Paclitaxel (Abraxane). | Q38964388 | ||
| Ocular Manifestations, Conventional Fundus Fluorescein Angiographic Findings, and Relationship Between Angiographic Findings and Visual Acuity in Behçet's Disease | Q38974902 | ||
| Nodular syphilitic scleritis masquerading as an ocular tumor | Q39226144 | ||
| Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in martinique (French West Indies). | Q39246250 | ||
| Prevalence of Noninfectious Uveitis in the United States: A Claims-Based Analysis | Q39409933 | ||
| A Focus on the Epidemiology of Uveitis | Q39551002 | ||
| Insights into the Physiopathology of Inflammatory Macular Edema. | Q51082779 | ||
| Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. | Q51832863 | ||
| The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema. | Q52228884 | ||
| Clinical Features and Prognosis of Uveitis in a Turkish Patient Population with Ankylosing Spondylitis: Incidence and Management of Ocular Complications. | Q52688458 | ||
| [Intraocular inflammation in multiple sclerosis]. | Q52807671 | ||
| Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital. | Q52885451 | ||
| Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients. | Q52935931 | ||
| The CD4/CD8 ratio in vitreous fluid is of high diagnostic value in sarcoidosis. | Q53126912 | ||
| Uveitis in Behçet disease: an analysis of 880 patients. | Q53285281 | ||
| Postsurgical Cystoid Macular Edema. | Q53395205 | ||
| Influence of the vitreomacular interface on the efficacy of intravitreal therapy for uveitis-associated cystoid macular oedema. | Q53599525 | ||
| Quantitative analysis of peripheral vasculitis, ischemia, and vascular leakage in uveitis using ultra-widefield fluorescein angiography. | Q53606178 | ||
| The effects of repeated Ozurdex injections on ocular hypertension. | Q53829701 | ||
| Single-eye trial of a topical carbonic anhydrase inhibitor versus intravitreal bevacizumab for the treatment of taxane drug-induced cystoid macula oedema. | Q54145708 | ||
| Prevalence of cystoid macular oedema, epiretinal membrane and cataract in retinitis pigmentosa | Q57021312 | ||
| Cystoid macular oedema and iris-fixated intraocular lens treated with intraocular lens exchange: A case series and review | Q57057560 | ||
| Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial | Q57072240 | ||
| Long-term Follow-up of Intermediate Uveitis in Children | Q57337614 | ||
| Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network | Q57612721 | ||
| Anti-TNF- therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients | Q57767895 | ||
| Coinfections and differential diagnosis in immunocompetent patients with uveitis of infectious origin | Q61443613 | ||
| Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis | Q61810687 | ||
| Management of Fingolimod-Associated Macular Edema | Q61873815 | ||
| Update in treatment of uveitic macular edema | Q64226421 | ||
| Cystoid macular edema following penetrating keratoplasty: incidence and prognosis | Q68885990 | ||
| Changing patterns of uveitis | Q69741227 | ||
| International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease | Q69741243 | ||
| Steroidal and nonsteroidal anti-inflammatory agents. Effect on postsurgical inflammation and blood-aqueous humor barrier breakdown | Q70386930 | ||
| Uveitis in London and Iowa | Q70597908 | ||
| Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents | Q71020371 | ||
| Endogenous uveitis: an analysis of 1,417 cases | Q71614315 | ||
| A uveitis register at the Leicester Royal Infirmary | Q71862512 | ||
| Outcomes of HLA-B27-Positive and HLA-B27-Negative Acute Anterior Uveitis | Q72026611 | ||
| Interferon-alpha 2b for refractory ocular Behçet's disease | Q72679027 | ||
| Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa | Q73444647 | ||
| Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center | Q74258850 | ||
| Outcomes in anterior uveitis associated with the HLA-B27 haplotype | Q77352414 | ||
| Uveitis | Q79732969 | ||
| Impact of macular edema on visual acuity in uveitis | Q80023608 | ||
| Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation | Q80332997 | ||
| Usefulness of aqueous humor analysis for the diagnosis of posterior uveitis | Q80721691 | ||
| Human leukocyte antigen-B27-associated uveitis: long-term follow-up and gender differences | Q80725917 | ||
| Infliximab for chronic cystoid macular edema associated with uveitis | Q80871601 | ||
| Sympathetic ophthalmia | Q81972030 | ||
| Does fingolimod in multiple sclerosis patients cause macular edema? | Q83200905 | ||
| Clinical features and prognosis of HLA B27-associated acute anterior uveitis in an Italian patient population | Q84008649 | ||
| Successful treatment of chronic pseudophakic macular edema (Irvine-Gass syndrome) with interferon alpha: a report of three cases | Q84147752 | ||
| Epidemiology of uveitis in Switzerland | Q84599588 | ||
| Cystoid macular edema in uveitis | Q84724872 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | uveitis | Q280027 |
| P304 | page(s) | 1761-1777 | |
| P577 | publication date | 2019-09-10 | |
| P1433 | published in | Clinical Ophthalmology | Q5133782 |
| P1476 | title | Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges | |
| P478 | volume | 13 |
| Q89761641 | Intraocular Inflammation Control and Changes in Retinal and Choroidal Architecture in Refractory Non-Infectious Uveitis Patients after Adalimumab Therapy | cites work | P2860 |
Search more.